Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Common Stock Net 2010-2025 | EVO

Evotec AG common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  
Evotec AG Annual Common Stock Net
(Millions of US $)
2024 $192
2023 $192
2022 $186
2021 $209
2020 $187
2019 $169
2018 $176
2017 $167
2016 $147
2015 $147
2014 $175
2013 $175
2012 $152
2011 $165
2010 $0
2009 $152
Evotec AG Quarterly Common Stock Net
(Millions of US $)
2025-06-30 $202
2025-03-31 $187
2024-12-31 $192
2024-09-30 $195
2024-06-30 $191
2024-03-31 $193
2023-09-30 $193
2023-06-30 $193
2022-12-31 $186
2022-09-30 $178
2022-06-30 $188
2022-03-31 $199
2021-12-31 $209
2021-09-30 $195
2021-06-30 $198
2021-03-31 $198
2020-12-31 $187
2020-09-30 $178
2020-06-30 $167
2020-03-31 $167
2019-12-31 $169
2019-09-30 $167
2019-06-30 $168
2019-03-31 $170
2018-12-31 $176
2018-09-30 $172
2018-06-30 $176
2018-03-31 $181
2017-12-31 $167
2017-09-30 $173
2017-06-30 $161
2017-03-31 $156
2016-12-31 $147
2016-09-30 $148
2016-06-30 $150
2016-03-31 $146
2015-12-31 $147
2015-09-30 $147
2015-06-30 $146
2015-03-31 $149
2014-12-31 $175
2014-09-30 $175
2014-06-30 $181
2014-03-31 $180
2013-12-31 $175
2013-09-30 $173
2013-06-30 $155
2013-03-31 $157
2012-12-31 $152
2012-09-30 $148
2012-06-30 $152
2012-03-31 $155
2011-12-31 $165
2011-09-30 $168
2011-06-30 $170
2011-03-31 $158
2010-12-31
2010-09-30 $140
2010-06-30 $139
2010-03-31 $151
2009-12-31 $152
2009-09-30 $156
2009-06-30 $148
2009-03-31 $142
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.293B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.494B 27.11
Zoetis (ZTS) United States $69.411B 25.18
Takeda Pharmaceutical (TAK) Japan $49.383B 10.08
Daiichi Sankyo, - (DSNKY) Japan $48.268B 24.74
BeOne Medicines - (ONC) Switzerland $34.378B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.623B 0.00
Summit Therapeutics (SMMT) United States $19.463B 0.00
Merck (MKKGY) Germany $17.015B 11.06
Shionogi (SGIOY) Japan $14.904B 0.00
United Therapeutics (UTHR) United States $14.084B 12.19
Neurocrine Biosciences (NBIX) United States $13.432B 40.07
IPSEN (IPSEY) France $11.429B 0.00
Orion OYJ (ORINY) Finland $11.336B 27.32
Eisai (ESAIY) $9.286B 10.47
Madrigal Pharmaceuticals (MDGL) United States $9.207B 0.00
Corcept Therapeutics (CORT) United States $7.411B 62.24
Grifols, S.A (GRFS) Spain $6.986B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Ionis Pharmaceuticals (IONS) United States $6.804B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Soleno Therapeutics (SLNO) United States $3.644B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.012B 14.31
Crinetics Pharmaceuticals (CRNX) United States $2.912B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.580B 8.64
Hypermarcas (HYPMY) Brazil $2.540B 19.09
Centessa Pharmaceuticals (CNTA) United Kingdom $2.278B 0.00
Ocular Therapeutix (OCUL) United States $2.140B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Dyne Therapeutics (DYN) United States $1.790B 0.00
Guardian Pharmacy Services (GRDN) United States $1.633B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Avadel Pharmaceuticals (AVDL) Ireland $1.480B 0.00
Ardelyx (ARDX) United States $1.472B 0.00
Harrow (HROW) United States $1.448B 0.00
ARS Pharmaceuticals (SPRY) United States $1.334B 0.00
Xeris Biopharma Holdings (XERS) United States $1.251B 0.00
Enliven Therapeutics (ELVN) United States $1.235B 0.00
Collegium Pharmaceutical (COLL) United States $1.232B 6.73
Cronos Group (CRON) Canada $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.846B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.829B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.744B 7.67
ProKidney (PROK) United States $0.709B 0.00
Theravance Biopharma (TBPH) United States $0.701B 57.96
KalVista Pharmaceuticals (KALV) United States $0.675B 0.00
Siga Technologies (SIGA) United States $0.654B 8.08
Relay Therapeutics (RLAY) United States $0.636B 0.00
Bioventus (BVS) United States $0.632B 15.28
Organogenesis (ORGO) United States $0.620B 0.00
Xencor (XNCR) United States $0.600B 0.00
Tourmaline Bio (TRML) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.589B 12.07
Elite Pharmaceuticals (ELTP) United States $0.588B 0.00
Oruka Therapeutics (ORKA) United States $0.578B 0.00
Savara (SVRA) United States $0.546B 0.00
Zevra Therapeutics (ZVRA) United States $0.530B 0.00
Nektar Therapeutics (NKTR) United States $0.514B 0.00
Nanobiotix S.A (NBTX) France $0.484B 0.00
Esperion Therapeutics (ESPR) United States $0.438B 0.00
Aquestive Therapeutics (AQST) United States $0.397B 0.00
Aldeyra Therapeutics (ALDX) United States $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.333B 0.00
4D Molecular Therapeutics (FDMT) United States $0.331B 0.00
Larimar Therapeutics (LRMR) United States $0.324B 0.00
Altimmune (ALT) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 18.85
AleAnna (ANNA) United States $0.275B 0.00
Lexeo Therapeutics (LXEO) United States $0.265B 0.00
Galectin Therapeutics (GALT) United States $0.263B 0.00
OmniAb (OABI) United States $0.227B 0.00
Heron Therapeutics (HRTX) United States $0.215B 0.00
Lyell Immunopharma (LYEL) United States $0.207B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.206B 31.75
Aclaris Therapeutics (ACRS) United States $0.195B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Korro Bio (KRRO) United States $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.182B 0.00
Journey Medical (DERM) United States $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
Profound Medical (PROF) Canada $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Avalo Therapeutics (AVTX) United States $0.130B 0.00
Avita Medical (RCEL) United States $0.130B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.120B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 23.84
Dominari Holdings (DOMH) United States $0.100B 0.00
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Liminatus Pharma (LIMN) United States $0.089B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
Wellgistics Health (WGRX) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Gain Therapeutics (GANX) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
DURECT (DRRX) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.055B 0.00
Jupiter Neurosciences (JUNS) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.91
Plus Therapeutics (PSTV) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Tempest Therapeutics (TPST) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Incannex Healthcare (IXHL) Australia $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Ainos (AIMD) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Aptorum Group (APM) United Kingdom $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.66
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.65
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00